Health Care Utilization and Costs in Lung Cancer Screening Participants-A Propensity-Matched Economic Analysis

Lung cancer screening (LCS) for high-risk populations has been firmly established to reduce lung cancer mortality, but concerns exist regarding unintended downstream costs. Mean health care utilization and costs were compared in the Alberta Lung Cancer Screening Study in a cohort undergoing LCS vers...

Full description

Saved in:
Bibliographic Details
Published in:JTO clinical and research reports 2023-12, Vol.4 (12), p.100594-100594, Article 100594
Main Authors: Tremblay, Alain, Premji, Shainur, Thanh, Nguyen Xuan, Yang, Huiming, MacEachern, Paul, Penz, Erika, Cressman, Sonya, Bedard, Eric L R
Format: Article
Language:English
Subjects:
Cost analysis
Low-dose CT scan
Lung cancer
Screening
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lung cancer screening (LCS) for high-risk populations has been firmly established to reduce lung cancer mortality, but concerns exist regarding unintended downstream costs. Mean health care utilization and costs were compared in the Alberta Lung Cancer Screening Study in a cohort undergoing LCS versus a propensity-matched control group who did not. A cohort of 651 LCS participants was matched to 336 unscreened controls. Over the study period (mean 3.6 y), a modest increase in the number of claims (22.4 versus 21.9 per person-year [PY]; Δ 0.50 [95% confidence interval: 0.15-0.86],  = 0.006) and outpatient visits (4.01 versus 3.50 per PY; Δ 0.51 [0.37-0.65],
ISSN:2666-3643
2666-3643
DOI:10.1016/j.jtocrr.2023.100594